Buch, Englisch, 444 Seiten, Format (B × H): 175 mm x 250 mm, Gewicht: 940 g
C C
Buch, Englisch, 444 Seiten, Format (B × H): 175 mm x 250 mm, Gewicht: 940 g
ISBN: 978-0-19-851589-0
Verlag: ACADEMIC
This is the first book devoted to the study of the social and economic consequences of headache. Reducing the Burden of Headache analyses the financial cost of headache diseases, the disability and suffering they cause and the impact they have on the quality of life of the sufferers and their families.
These are issues of major importance; migraine appears in the top 20 list of diseases ranked according to years lived with disability. Headache, in general, is thought to account for approximately 20% of all days lost from work. Of even greater importance is the impact on everyday life, studies have shown that migraine has a greater impact on the quality of life of sufferers than many other diseases generally considered to be more serious.
This book describes and analyses the epidemiological data accumulated in the field and suggests guidelines and interventions aimed at improving healthcare for headache. Adoption of these suggestions combined with judicious use of existing resources and modern treatment options can lead to great improvements in the lives of headache sufferers world-wide.
This book will be of interest to neurologists, general practitioners, epidemiologists, public health specialists, health service managers and all those interested in improving services and outcomes for sufferers of headache.
Zielgruppe
The readership will include neurologists caring for headache patients and those with research interests in the field, general practitioners, epidemiologists, public health specialists, health service managers, and researchers working in the pharmaceutical industry.
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Präventivmedizin, Gesundheitsförderung, Medizinisches Screening
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
Weitere Infos & Material
- Section I - Headache-related disability
- 1: Lipton, Scher and Stewart: Overview of headache prevalence, burden and management
- 2: Scher, Lipton and Stewart: Measuring headache disability
- 3: Dahlöf: Benefits of treatment on headache disability - a personal view on selected data
- 4: Magnusson and Becker: Comparing disability and psychological factors in migraine and transformed migraine
- 5: Farmer, Cady, Reeves and Bleiberg: Cognitive efficiency following migraine therapy
- 6: Harmoussi-Peiglou, Dimitriadis and Vlachogianni: Comparative evolution of MIDAS score after monotherapy with triptans
- 7: Sakai, Igarashi and Iigaya: Disability-adjusted life years (DALYs) and MIDAS in Japan
- 8: Evers, Bauer, Gralow and Husstedt: Disability in German headache sufferers: evaluation of a German headache disability inventory
- 9: Chauvet and MacGregor: MIDAS as a tool for monitoring the benefits of treatment strategies over time
- 10: Grazzi, D'Amico, Andrasik, Usai, Leone, Rigamonti and Bussone: The MIDAS questionnaire in children and young adolescents with headache: a pilot study
- 11: D'Amico, Usai, Solari, Grazzi, Leone, Rigamonti and Bussone: Relationship between disability and quality of life in migraine
- 12: Henry, Auray, Duru, Chazot, Dartigues, Lantéri-Minet, Lucas, Pradalier, El Hasnaoui and Gaudin: Migraine in France in 2000: epidemiological data
- 13: Bjorner, Ware, Kosinski, Diamond, Tepper, Dowson, Bayliss and Batenhorst: Validation of the Headache Impact Test (TM) using patient-reported symptoms and headache severity
- 14: Steiner: Headache-related disability: discussion summary
- Section II - Patient-centred measures: health-related quality of life
- 15: Henry, Chrysostome, Michel and Dartigues: Measuring health-related quality of life: general principles
- 16: Terwindt, Ferrari and Launer: Effect of headache on quality of life
- 17: Martin, Pathak, Kwong, Batenhorst and Sharfman: Assessment of the responsiveness of the Migraine-Specific Quality of Life Questionnaire (version 2.1)
- 18: Funk-Orsini, Miceli, Mackell and Wells: Comparison of the impact of eletriptan versus sumatriptan on migraine-specific quality of life
- 19: D'Amico, Rigamonti, Solari, Leone, Usai, Grazzi and Bussone: Impact of cluster headache on health-related quality of life
- 20: Funk-Orsini, Miceli, Mackell and Wells: Improvement in migraine-specific quality of life with eletriptan (Relpax (TM)) as compared to Cafergot (R)
- 21: Burke, Kwong and Batenhorst: Improvements in health-related quality of life with long-term use of sumatriptan therapy for migraine
- 22: Mannix, Kwong, Skinner and Dimsdale: Psychometric evaluation of a computerised program to assess migraine-specific quality of life in clinical practice
- 23: D'Amico, Grazzi, Usai, Solari, Leone, Rigamonti and Bussone: Quality of life and disability in transformed migraine with drug overuse
- 24: Láinez, Leira, Pascual, Díez Tejedor, Morales, Titus and Alberca: Quality of life and migraine: a multicentre Spanish study
- 25: Göbel: Patient-centred measures: health-related quality of life: discussion summary
- Section III - Family burden, comorbidities and health-care utilization
- 26: Smith and Hasse: Family impact of migraine
- 27: Breslau: Migraine comorbidity with stroke, epilepsy and major depression
- 28: Krogh Rasmussen: Health care utilization for headache
- 29: Limmroth and Hettiarachchi: Functional improvement in migraine patients treated with oral eletriptan versus sumatriptan: a pooled analysis
- 30: Göbel, Buschmann and Heinze: Health-care utilization for in-patient headache therapy
- 31: Schreiber and Cady: Self-described 'sinus headache' and headache related impact
- 32: Bülow-Olsen: Reducing the personal burden of migraine: a patient's perspective
- 33: Catarci, Baldinetti and Granella: The burden of migraine in a sample of doctors of an Italian general hospital in Rome
- 34: Lucas, Lantéri-Minet and Chaffaut: The Framig 2000 (II) survey: therapeutical data
- 35: Lucas, Lantéri-Minet and Chaffaut: The Framig 2000 (III) survey: health-care use
- 36: Lipton: Family Burden, comorbidities and health-care utilization: discussion summary
- Section IV - Economics of headache
- 37: Jonsson: General principles of disease-costing
- 38: Dartigues, Michel and Henry: The economic burden of headache
- 39: Wells: Measuring the economic benefits of pharmacotherapy: general principles
- 40: Halpern: Economic cost and benefit of pharmacotherapy for headache
- 41: Charlesworth, Lipton and Stewart: A stratified approach to migraine management including zolmitriptan is clinically and economically superior to step care approaches: results from the Disability in Strategies of Care (DISC) study
- 42: Wells: A comparative study of the effectiveness of eletriptan, Cafergot (R) and sumatriptan in reducing the time loss associated with migraine attacks
- 43: Láinez, Monzón and The Spanish Occupational Migraine Study Group: The socio-economic impact of migraine in Spain
- 44: Silberstein, Winner and Chmiel: Reductions in medical and pharmacy resource utilization associated with the addition of preventive medication to the migraine management strategy
- 45: Folino-Gallo, Palazzo, Stirparo, De Filippis and Martelletti: Utilization and price differentials of selective 5-HT1-receptor agonists in the European countries
- 46: Wells: Regaining time lost during migraine attacks with eletriptan
- 47: Olesen: Economics of headache: discussion summary
- Section V - Guidelines and interventions
- 48: Silberstein: Evidence-based guidelines for migraine headache
- 49: Maizels: Model interventions to improve headache outcomes in health-care systems
- 50: Stewart and Lipton: Model interventions to improve headache outcomes in the workplace
- 51: Mihout, Lantéri-Minet, Slama and Nachit-Ouinekh: Analysis of headache patient's behaviour in the pharmacy: results of a French multicentre study
- 52: Göbel, Petersen-Braun and Heinze: Comparison of the efficacy of self-medication and medical prescriptions in reducing the burden of headache
- 53: Finkelstein, Berndt, Pransky and Mackell: Evaluation of migraine in the workplace
- 54: Torelli and Manzoni: Headache patient management in 21 Italian headache centres
- 55: Nachit-Ouinekh, El Amrani, El Hasnaoui and the National Orientation Committee: Migraine and chronic idiopathic headache in the French workforce: detection and management: the NOEMIE study protocol
- 56: Bayliss, Kosinski, Diamond, Tepper, Garber, Ware and Batenhorst: HIT-6 (TM) scores discriminate among headache sufferers differing in headache-associated workplace productivity loss
- 57: Diener: Guidelines and interventions: discussion summary
- Section VI - Improving health-care systems for headache
- 58: Steiner: Integrating headache services across the primary/secondary care interface
- 59: Göbel: Comprehensive academic headache centres
- 60: Diener: Headache clinic or pain centre: together or separate
- 61: Valade, Ducros, El Amrani, Ben slamia, Roos, Djomby, Domigo, Morin, Besançon and Bousser: The first year of the Lariboisière emergency headache centre: a series of 10510 patients
- 62: Smith, Hasse, Richey, Cassedy and Rudawsky: Headache symptoms and other headache features in non-specified headaches in primary care
- 63: Borrell-Wilson and Cahill-Wright: Headache treatment outcome: a proposed paradigm for quantitative anaylsis
- 64: Bayliss, Bjorner, Kosinski, Dahlöf, Dowson, Cady, Ware and Batenhorst: Development of HIT-6 (TM), a paper-based short form for measuring headache impact
- 65: Stovner, Hagen, Vattan, Zwart, Krokstad and Bovim: Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway
- 66: Göbel, Buschmann, Heinze, Püffel, Krüger, Meyer, Nicola and Polano: Reducing the burden of headache by communicating treatment strategies for employees
- 67: Cady, Farmer, Schreiber and Kaniecki: The usefulness of the publication Patient-centred strategies for effective management of migraine, in primary care
- 68: Silberstein: Improving health-care systems for headache: discussion summary
